MERRIMACK PHARMACEUTICALS INC Depreciation
MERRIMACK PHARMACEUTICALS INC reported Depreciation of $2.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2020-03-12
- MERRIMACK PHARMACEUTICALS INC depreciation for fiscal 2019 was $2.20M, a 46.34% decline from fiscal 2018.
- MERRIMACK PHARMACEUTICALS INC depreciation for fiscal 2018 was $4.10M, a 19.61% decline from fiscal 2017.
- MERRIMACK PHARMACEUTICALS INC depreciation for fiscal 2017 was $5.10M, a 21.54% decline from fiscal 2016.
- MERRIMACK PHARMACEUTICALS INC depreciation for fiscal 2016 was $6.50M, a 35.42% increase from fiscal 2015.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2019-12-31 | $2.20M 10-K · filed 2020-03-12 | |
| 2018-12-31 | $4.10M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $5.10M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $6.50M 10-K · filed 2018-03-12 | $7.30M 10-K · filed 2017-03-01 |
| 2015-12-31 | $4.80M 10-K · filed 2018-03-12 | $5.50M 10-K · filed 2016-02-26 |
| 2014-12-31 | $3.70M 8-K · filed 2017-12-15 | $4.20M 10-K · filed 2015-02-27 |
| 2013-12-31 | $2.80M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $3.50M 10-K · filed 2015-02-27 | $3.51M 10-K · filed 2013-03-20 |
| 2011-12-31 | $5.00M 10-K · filed 2014-03-04 | $5.01M 10-K · filed 2013-03-20 |
| 2010-12-31 | $4.06M 10-K · filed 2013-03-20 |